Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33:1659–1672. https://doi.org/10.1097/IAE.0b013e3182953df4

Article  PubMed  Google Scholar 

Dansingani KK, Balaratnasingam C, Naysan J, Freund KB (2016) En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 36:499–516. https://doi.org/10.1097/IAE.0000000000000742

Article  PubMed  Google Scholar 

Spaide RF, Gemmy Cheung CM, Matsumoto H et al (2021) Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res 86:100973. https://doi.org/10.1016/j.preteyeres.2021.100973

Article  CAS  PubMed  Google Scholar 

Sharma A, Parachuri N, Kumar N et al (2021) Vortex vein anastomosis and pachychoroid-an evolving understanding. Eye 35:1545–1547. https://doi.org/10.1038/s41433-021-01423-2

Article  PubMed  PubMed Central  Google Scholar 

Ersoz MG, Arf S, Hocaoglu M et al (2018) Indocyanıne green angiography of pachychoroid pigment epitheliopathy. Retina 38:1668–1674. https://doi.org/10.1097/IAE.0000000000001773

Article  PubMed  Google Scholar 

Matsumoto H, Hoshino J, Mukai R et al (2021) Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy. Sci Rep 11:16274. https://doi.org/10.1038/s41598-021-95904-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1–9. https://doi.org/10.1097/IAE.0000000000000331

Article  CAS  PubMed  Google Scholar 

Yanagi Y (2020) Pachychoroid disease: a new perspective on exudative maculopathy. Jpn J Ophthalmol 64:323–337. https://doi.org/10.1007/s10384-020-00740-5

Article  PubMed  Google Scholar 

Miyake M, Ooto S, Yamashiro K et al (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https://doi.org/10.1038/srep16204. (PMID: 26542071)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baek J, Kook L, Lee WK (2019) Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep 9:5565. https://doi.org/10.1038/s41598-019-42052-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500. https://doi.org/10.1016/j.ajo.2008.05.032

Article  PubMed  Google Scholar 

Dansingani KK, Perlee LT, Hamon S et al (2016) Risk alleles associated with neovascularization in a pachychoroid phenotype. Ophthalmology 123:2628–2630. https://doi.org/10.1016/j.ophtha.2016.06.060

Article  PubMed  Google Scholar 

Elfandi S, Ooto S, Miyata M et al (2021) Effects of intravitreous aflibercept injection in pachychoroid neovasculopathy: comparison with typical neovascular age-related macular degeneration. Clin Ophthalmol 15:1539–1549. https://doi.org/10.2147/OPTH.S285257

Article  PubMed  PubMed Central  Google Scholar 

Cho HJ, Jung SH, Cho S et al (2019) Intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. J Ocul Pharmacol Ther 35:174–181. https://doi.org/10.1089/jop.2018.0107

Article  CAS  PubMed  Google Scholar 

Yoon J, Yoon W, Na SK et al (2021) Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. Sci Rep 11:12052. https://doi.org/10.1038/s41598-021-91589-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto H, Hiroe T, Morimoto M et al (2018) Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol 62:144–150. https://doi.org/10.1007/s10384-018-0562-0

Article  CAS  PubMed  Google Scholar 

Li X, Zhu Q, Egger A, Chang L, Wolf S, Song Y et al (2021) Two different treatment regimens of ranibizumab 0.5 mg for neovascular age-related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study. Acta Ophthalmol 99:e336–345. https://doi.org/10.1038/s41598-019-38504-y

Article  CAS  PubMed  Google Scholar 

Hatz K, Prünte C (2017) Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study. Acta Ophthalmol 95:e67–e72. https://doi.org/10.1111/aos.13031

Article  CAS  PubMed  Google Scholar 

Lee JH, Lee WK (2016) One-year results of adjunctive photodynamic therapy for type 1 neovascularization associated with thickened choroid. Retina 36:889–895. https://doi.org/10.1097/IAE.0000000000000809

Article  CAS  PubMed  Google Scholar 

Guymer RH, Markey CM, McAllister IL et al (2019) Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results. Ophthalmology 126:723–734. https://doi.org/10.1016/j.ophtha.2018.11.025

Article  PubMed  Google Scholar 

Sadda S, Holekamp NM, Sarraf D et al (2022) Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis. Graefes Arch Clin Exp Ophthalmol 260:3781–378. https://doi.org/10.1007/s00417-022-05716-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li E, Donati S, Lindsley KB et al (2020) Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. Cochrane Database Syst Rev 5(5):CD012208. https://doi.org/10.1002/14651858.CD005139.pub4

PubMed  Google Scholar 

Jung BJ, Kim JY, Lee JH et al (2019) Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep 9:1–7. https://doi.org/10.1038/s41598-019-38504-y

Google Scholar 

Martin DF, Maguire MG, Fine SL et al (2012) Comparison of Age-Related Macular Degeneration Treatments Trial (CATT) Research Group. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119:1388–1398. https://doi.org/10.1016/j.ophtha.2012.03.053

Article  PubMed  Google Scholar 

Solomon SD, Lindsley KB, Krzystolik MG et al (2016) Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a Cochrane systematic review. Ophthalmology 123:70–77.e1. https://doi.org/10.1002/14651858.CD005139.pub4

Article  PubMed  Google Scholar 

Selid PD, Jundt MC, Fortney AC, Beal JR (2014) Intravitreal bevacizumab and aflibercept for the treatment of exudative age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 45:275–281. https://doi.org/10.3928/23258160-20140709-03

Article  PubMed  Google Scholar 

Heier JS, Brown DM, Chong V et al (2012) VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537–2548. https://doi.org/10.1016/j.ophtha.2012.09.006

Article  PubMed  Google Scholar 

Rao P, Lum F, Wood K et al (2018) Real-world vision in age-related macular degeneration patients treated with single anti-VEGF drug type for 1 year in the IRIS registry. Ophthalmology 125:522–528. https://doi.org/10.1016/j.ophtha.2017.10.010

Article  PubMed  Google Scholar 

Koizumi H, Kano M, Yamamoto A et al (2016) Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration.: Twelve-Month Results. Ophthalmology 123:617–624. https://doi.org/10.1016/j.ophtha.2015.10.039

Article  PubMed  Google Scholar 

Lee WK, Baek J, Dansingani KK et al (2016) Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina 36(Suppl 1):S73–S82. https://doi.org/10.1097/IAE.0000000000001346

Article  PubMed  Google Scholar 

Demirel S, Yanık Ö, Nalcı H et al (2017) The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefes Arch Clin Exp Ophthalmol 255:2317–2324. https://doi.org/10.1007/s00417-017-3793-8

Article  PubMed  Google Scholar 

Cheung CMG, Lai TYY, Teo K et al (2021) Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup. Ophthalmology 128:443–452. https://doi.org/10.1016/j.ophtha.2020.08.006

Article  PubMed  Google Scholar 

Chaikitmongkol V, Kong J, Khunsongkiet P et al (2019) Sensitivity and Specificity of Potential Diagnostic Features Detected Using Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography for Polypoidal Choroidal Vasculopathy. JAMA Ophthalmol 137(6):661–667. https://doi.org/10.1001/jamaophthalmol.2019.0565

Article  PubMed  PubMed Central  Google Scholar 

Liu R, Li J, Li Z et al (2016) Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 36(4):778–786. https://doi.org/10.1097/IAE.0000000000000794

Article  PubMed  Google Scholar